Cellular interactions of platinum drugs

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Inorganica Chimica Acta

• Publication date

  2012-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.ICA.2012.07.013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Pharmacokinetics and Administration of Established Platinum Drugs

  2012cited by this paper
• Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin

  2012cited by this paper
• Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator

  2011cited by this paper
• [Cisplatin or carboplatin, that is the question].

  2011cited by this paper
• p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

  2011cited by this paper
• Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA

  2010cited by this paper
• The status of platinum anticancer drugs in the clinic and in clinical trials.

  2010cited by this paper
• Proteomic and metallomic strategies for understanding the mode of action of anticancer metallodrugs.

  2010cited by this paper
• Platinum–DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes

  2010cited by this paper
• Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer

  2010cited by this paper
• Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.

  2009cited by this paper
• Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.

  2009cited by this paper
• Molecular origin of the sequence-dependent kinetics of reactions between cisplatin derivatives and DNA

  2009cited by this paper
• Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate.

  2009cited by this paper
• Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts.

  2009cited by this paper
• The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

  2008cited by this paper
• How do real tumors become resistant to cisplatin?

  2008cited by this paper
• Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.

  2008cited by this paper
• Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1

  2008cited by this paper
• cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

  2008cited by this paper
• 195Pt NMR--theory and application.

  2007cited by this paper
• Mechanisms of resistance to cisplatin and carboplatin.

  2007cited by this paper
• Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations.

  2007cited by this paper
• Interaction between platinum complexes and a methionine motif found in copper transport proteins.

  2007cited by this paper
• Understanding cisplatin resistance using cellular models

  2007cited by this paper
• The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours.

  2006cited by this paper
• Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding.

  2006cited by this paper
• Elucidating the hard/soft acid/base principle: a perspective based on half-reactions.

  2006cited by this paper
• Organic cation transporters are determinants of oxaliplatin cytotoxicity.

  2006cited by this paper
• The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR

  2006cited by this paper
• Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy

  2006cited by this paper
• Ligand K-edge x-ray absorption spectroscopy: Covalency of ligand-metal bonds

  2005cited by this paper
• Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge.

  2005cited by this paper
• Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)] x HCl complexes with ubiquitin.

  2005cited by this paper
• Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.

  2005cited by this paper
• Trafficking and localization of platinum complexes in cisplatin‐resistant cell lines monitored by fluorescence‐labeled platinum

  2005cited by this paper
• Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.

  2005cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Dinuclear platinum anticancer complexes with fluorescent N,N′-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles

  2005cited by this paper
• No Correlation between GSH Levels in Human Cancer Cell Lines and the Cell Growth Inhibitory Activities of Platinum Diamine Complexes

  2004cited by this paper
• Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance

  2004cited by this paper
• Dinuclear platinum complexes with N,N′-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells

  2004cited by this paper
• XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents.

  2003cited by this paper
• The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells

  2003cited by this paper
• Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.

  2003cited by this paper
• Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.

  2002cited by this paper
• DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.

  2002cited by this paper
• Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines.

  2002cited by this paper
• Lobaplatin: a new antitumour platinum drug

  2001cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• EXAFS characterization of supported metal-complex and metal-cluster catalysts made from organometallic precursors

  2000cited by this paper
• New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy

  2000cited by this paper
• BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

  2000cited by this paper
• Evolution of esi–mass spectrometry and fourier transform ion cyclotron resonance for proteomics and other biological applications

  2000cited by this paper
• Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

  1999cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells.

  1999cited by this paper
• Oxaliplatin: a new therapeutic option in colorectal cancer.

  1999cited by this paper
• Interconversion between S- and N-bound L-methionine adducts of Pt(dien)2+ (dien = diethylenetriamine) via dien ring-opened intermediates

  1998cited by this paper
• Donor atom preferences in complexes of platinum and palladium with amino acids and related molecules

  1997cited by this paper
• Intramolecular migration of co-ordinated platinum from a sulfur to N7 in the nucleopeptide Met-d(TpG) (5′-O-methioninate-N-ylcarbonylthymidine 2′-deoxyguanosine monophosphate)†

  1997cited by this paper
• Structural studies of interactions between anticancer platinum drugs and DNA.

  1996cited by this paper
• The events that occur when cisplatin encounters cells

  1996cited by this paper
• Cisplatin adducts in DNA: distortion and recognition

  1996cited by this paper
• Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

  1995cited by this paper
• Cisplatin: a clinical review. Part II--Nursing assessment and management of side effects of cisplatin.

  1994cited by this paper
• Intermolecular displacement of S-bound L-methionine on platinum(II) by guanosine 5′-monophosphate: implications for the mechanism of action of anticancer drugs

  1994cited by this paper
• A trans-platinum complex showing higher antitumor activity than the cis congeners.

  1993cited by this paper
• Cellular accumulation of the anticancer agent cisplatin: a review.

  1993cited by this paper
• Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.

  1993cited by this paper
• A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).

  1992cited by this paper
• Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-[1H] DEPT NMR.

  1990cited by this paper
• Cytostatic trans-platinum(II) complexes.

  1989cited by this paper
• Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.

  1989cited by this paper
• X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))].

  1985cited by this paper
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

  1985cited by this paper
• Reactions of platinum(II) aqua complexes. 3. Multinuclear (15N, 195Pt, 13C, and 1H) NMR study of reactions of aqua and hydroxo complexes with glycine and (methylimino)diacetic acid

  1985cited by this paper
• Reactions of platinum(II) aqua complexes. 3. Multinuclear (nitrogen-15, platinum-195, carbon-13, and proton) NMR study of reactions of aqua and hydroxo complexes with glycine and (methylimino)diacetic acid

  1985cited by this paper
• Reactions of platinum(II) aqua complexes. 2. Platinum-195 NMR study of reactions between the tetraaquaplatinum(II) cation and chloride, hydroxide, perchlorate, nitrate, sulfate, phosphate, and acetate

  1985cited by this paper
• Reactions of platinum(II) aqua complexes. 1. Multinuclear (platinum-195, nitrogen-15, and phosphorus-31) NMR study of reactions between the cis-diamminediaquaplatinum(II) cation and the oxygen-donor ligands hydroxide, perchlorate, nitrate, sulfate, phosphate, and acetate

  1984cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper

• Amphiphilic Cu(II) Oxacyclen Complexes: From Oxidative Cleavage to Condensation of DNA

  2026cites this paper
• Transcriptome-wide mapping reveals an RNA-dependent mechanism of platinum cancer drugs

  2025cites this paper
• Facial Amphiphile-Modified Lipids Highly Sensitize Liposomes toward Secretory Phospholipase A2.

  2024cites this paper
• DFT Computational Analysis of the Mechanism of Action of Ru(II) Polypyridyl Complexes as Photoactivated Chemotherapy Agents: From Photoinduced Ligand Solvolysis to DNA Binding.

  2024cites this paper
• Recent Advances on Pt-Based Compounds for Theranostic Applications

  2024cites this paper
• An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy

  2023cites this paper
• Synergistic effects of combined cisplatin and Clinacanthus nutans extract on triple negative breast cancer cells

  2023cites this paper
• Curcuminoid Co-Loading Platinum Heparin-Poloxamer P403 Nanogel Increasing Effectiveness in Antitumor Activity

  2022cites this paper
• Influence of Ring Modifications on Nucleolar Stress Caused by Oxaliplatin‐Like Compounds **

  2022cites this paper
• Time-Dependent Studies of Oxaliplatin and Other Nucleolar Stress-Inducing Pt(II) Derivatives.

  2022cites this paper
• Pt-ttpy, a G-quadruplex binding platinum complex, induces telomere dysfunction and G-rich regions DNA damage.

  2021cites this paper
• Green Synthesis of Platinum and Palladium Nanoparticles Using Peganum harmala L. Seed Alkaloids: Biological and Computational Studies

  2021cites this paper
• Near-infrared emitting fluorescent homobimetallic gold(I) complexes displaying promising in vitro and in vivo therapeutic properties.

  2021cites this paper
• Anticancer Investigation of Platinum and Copper-Based Complexes Containing Quinoxaline Ligands

  2021cites this paper
• Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.

  2020cites this paper
• Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes

  2020cites this paper
• Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models

  2020cites this paper
• Synthesis, Antiproliferative Activity, and DNA Binding Studies of Nucleoamino Acid-Containing Pt(II) Complexes

  2020cites this paper
• Metal complexes in medicine and pharmacy - the past and the present II.

  2020cites this paper
• Oxidation of cis-diamminediacetato Pt(II) with hydrogen peroxide can give rise to two isomeric Pt(IV) products.

  2020cites this paper
• Top-down mass spectrometry reveals multiple interactions of an acetylsalicylic acid bearing Zeise’s salt derivative with peptides

  2020cites this paper
• Towards Overcoming Drug Resistance in Ovarian Tumour Models 2 Sequenced Combinations of Cisplatin and Selected Phytochemicals

  2020cites this paper
• Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.

  2019cites this paper
• Nucleolar Stress Induction by Oxaliplatin and Derivatives.

  2019cites this paper
• Cisplatin: The first metal based anticancer drug.

  2019cites this paper
• Synthesis, characterization, cytotoxic activity, and 19F NMR spectroscopic investigations of (OC-6-33)-diacetato(ethane-1,2-diamine)bis(3,3,3-trifluoropropanoato)platinum(IV) and its platinum(II) counterpart

  2019cites this paper
• In vitro and in vivo evaluation of first-generation carbosilane arene Ru(II)-metallodendrimers in advanced prostate cancer

  2019cites this paper
• Tracking the cellular targets of platinum anticancer drugs: Current tools and emergent methods

  2019cites this paper
• Light It Up: A Pre-Clinical Fluorescent Model to Illustrate Immunogenic Cell Death

  2018cites this paper
• Pre-/post-functionalization in dipyrrin metal complexes - antitumor and antibacterial activity of their glycosylated derivatives.

  2018cites this paper
• Zeise's salt as powerful platinating agent for proteins investigated by top-down-mass spectrometry.

  2018cites this paper
• Binding of platinum derivative, oxaliplatin to deoxyribonucleic acid: structural insight into antitumor action

  2018cites this paper
• Synergic Activity Against MCF-7 Breast Cancer Cell Growth of Nanocurcumin-Encapsulated and Cisplatin-Complexed Nanogels

  2018cites this paper
• Thermosensitive heparin-Pluronic® copolymer as effective dual anticancer drugs delivery system for combination cancer therapy

  2018cites this paper
• Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities

  2017cites this paper
• Cytotoxic platinum coordination compounds. DNA binding agents

  2017cites this paper
• Oxaliplatin reacts with DMSO only in the presence of water

  2017cites this paper
• A pH responsive complexation-based drug delivery system for oxaliplatin

  2017cites this paper
• Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery.

  2017cites this paper
• Effects of Binding Affinity between Bovine Serum Albumin and Platinum Drugs

  2017cites this paper
• Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action

  2016cites this paper
• Aquated cisplatin and heparin-pluronic nanocomplexes exhibiting sustainable release of active platinum compound and NCI-H460 lung cancer cell antiproliferation

  2016cites this paper
• Cytotoxic trans-platinum(II) complex with 3-hydroxymethylpyridine: Synthesis, X-ray structure and biological activity evaluation.

  2016cites this paper
• The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.

  2016cites this paper
• Covalent and non-covalent binding of metal complexes to RNA.

  2016cites this paper
• Multifunctional Pt(II) Reagents: Covalent Modifications of Pt Complexes Enable Diverse Structural Variation and In-Cell Detection.

  2016cites this paper
• Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.

  2016cites this paper
• Fluorinated Fe(III) salophene complexes: optimization of tumor cell specific activity and utilization of fluorine labeling for in vitro analysis.

  2015cites this paper
• Novel platinum–palladium bimetallic nanoparticles synthesized by Dioscorea bulbifera: anticancer and antioxidant activities

  2015influential citation
• Azide vs Alkyne Functionalization in Pt(II) Complexes for Post-treatment Click Modification: Solid-State Structure, Fluorescent Labeling, and Cellular Fate.

  2015cites this paper
• The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.

  2015cites this paper
• An alkyne-appended, click-ready Pt(II) complex with an unusual arrangement in the solid state.

  2015cites this paper
• Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin–Platinum(II) Complex

  2015cites this paper
• Convenient detection of metal-DNA, metal-RNA, and metal-protein adducts with a click-modified Pt(II) complex.

  2015cites this paper
• Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?

  2014cites this paper
• Synthesis, in‐vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2‐hydroxymethylbenzimidazole as carrier ligands

  2014cites this paper
• Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate.

  2014cites this paper
• Water-soluble platinum phthalocyanines as potential antitumor agents

  2014cites this paper
• Synthesis and Pharmacological Evaluation of Modified Adenosines Joined to Mono-Functional Platinum Moieties

  2014cites this paper
• Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions.

  2013cites this paper
• Picazoplatin, an azide-containing platinum(II) derivative for target analysis by click chemistry.

  2013cites this paper
• Synthesis and characterization of Novel Di- and Tetracarboxylatoplatinum(IV) complexes

  2013cites this paper
• Cisplatin Induces Differentiation of Breast Cancer Cells

  2012cites this paper